Skip to content

Eosinophilic Gastrointestinal Disorders Patient Registry

Eosinophilic Gastrointestinal Disorders Patient Registry

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01779154
Enrollment
0
Registered
2013-01-30
Start date
2013-01-31
Completion date
2017-05-31
Last updated
2016-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eosinophilic Colitis, Eosinophilic Enteritis, Eosinophilic Esophagitis, Eosinophilic Gastritis

Keywords

eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis

Brief summary

The Eosinophilic Gastrointestinal Disorders (EGIDS) Registry is a longitudinal study that does not involve medical interventions, but serves as a record of demographics, characteristics of disease and treatment, utilization patterns, quality improvement measures and clinical outcomes. The database is proposed so that epidemiologic research can be performed and current and accurate data can be obtained regarding practice patterns, age and gender distributions, efficacy of treatment, clinical outcomes and changes in quality of life.

Interventions

None listed

Sponsors

Arkansas Children's Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 21 Years
Healthy volunteers
No

Inclusion criteria

* male or female participants of any race or ethnicity * age 0 to 21 years * diagnosis of EGID including: eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis

Exclusion criteria

* hypereosinophilic syndrome * non-eosinophilic gastrointestinal or allergic disorder

Design outcomes

Primary

MeasureTime frameDescription
To define characteristics of an eosinophilic gastrointestinal disorder population in a rural southern stateAfter 12 months of data collectionTo develop a database of patients with eosinophilic gastrointestinal disorders so that epidemiologic research can be performed and current data can be obtained regarding practice patterns, age and gender distributions, efficacy of treatment, clinical outcomes and changes in quality of life.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026